These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 15633152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mesalazine as a maintenance treatment in Crohn's disease.
    Sutherland LR, Steinhart AH.
    Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM, Brzezinski A, Lashner BA.
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
    Kamm MA.
    Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The case for using 5-aminosalicyclates in Crohn's disease: pro.
    Hanauer SB.
    Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710
    [Abstract] [Full Text] [Related]

  • 16. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC, Hanauer S.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008870. PubMed ID: 21154400
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO, Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E.
    N Engl J Med; 1998 Aug 06; 339(6):370-4. PubMed ID: 9691103
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.